Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $562.70 | 6 | 89.7% |
| Education | $64.95 | 1 | 10.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Arcutis Biotherapeutics, Inc. | $150.56 | 1 | $0 (2024) |
| Celgene Corporation | $135.11 | 1 | $0 (2017) |
| Genentech USA, Inc. | $118.75 | 1 | $0 (2017) |
| Lilly USA, LLC | $99.79 | 1 | $0 (2017) |
| Janssen Biotech, Inc. | $64.95 | 1 | $0 (2018) |
| AbbVie, Inc. | $41.82 | 1 | $0 (2017) |
| Allergan Inc. | $16.67 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $150.56 | 1 | Arcutis Biotherapeutics, Inc. ($150.56) |
| 2018 | $64.95 | 1 | Janssen Biotech, Inc. ($64.95) |
| 2017 | $412.14 | 5 | Celgene Corporation ($135.11) |
All Payment Transactions
7 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/09/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $150.56 | General |
| Category: Dermatology | ||||||
| 05/25/2018 | Janssen Biotech, Inc. | Tremfya (Drug) | Education | In-kind items and services | $64.95 | General |
| Category: Immunology | ||||||
| 11/09/2017 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $99.79 | General |
| 06/08/2017 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $41.82 | General |
| Category: Immunology | ||||||
| 04/06/2017 | Genentech USA, Inc. | Erivedge (Biological) | Food and Beverage | In-kind items and services | $118.75 | General |
| Category: BioOncology | ||||||
| 04/01/2017 | Allergan Inc. | KYBELLA (Biological) | Food and Beverage | In-kind items and services | $16.67 | General |
| 03/23/2017 | Celgene Corporation | Otezla (Drug) | Food and Beverage | In-kind items and services | $135.11 | General |
| Category: Dermatology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 673 | 1,012 | $306,480 | $41,779 |
| 2022 | 12 | 762 | 1,310 | $386,020 | $51,808 |
| 2021 | 13 | 793 | 1,351 | $379,205 | $54,508 |
| 2020 | 11 | 637 | 948 | $273,658 | $37,361 |
All Medicare Procedures & Services
45 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 197 | 233 | $76,890 | $13,173 | 17.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 70 | 82 | $40,180 | $6,949 | 17.3% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 118 | 146 | $64,970 | $5,761 | 8.9% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 62 | 68 | $34,680 | $5,490 | 15.8% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 78 | 80 | $36,800 | $4,814 | 13.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 34 | 34 | $16,490 | $2,570 | 15.6% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 75 | 330 | $26,400 | $1,666 | 6.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 28 | 28 | $6,440 | $982.16 | 15.3% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 11 | 11 | $3,630 | $373.26 | 10.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 178 | 223 | $69,799 | $12,953 | 18.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 66 | 83 | $38,595 | $6,774 | 17.6% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 69 | 84 | $40,740 | $6,626 | 16.3% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 81 | 96 | $41,760 | $6,440 | 15.4% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 119 | 163 | $69,275 | $5,593 | 8.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 49 | 49 | $22,540 | $3,451 | 15.3% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 86 | 473 | $37,840 | $2,323 | 6.1% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 26 | 49 | $15,435 | $1,946 | 12.6% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 15 | 17 | $22,780 | $1,837 | 8.1% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 38 | 38 | $12,084 | $1,631 | 13.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 16 | 16 | $10,992 | $1,483 | 13.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 19 | 19 | $4,180 | $752.04 | 18.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 151 | 183 | $54,255 | $10,599 | 19.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 68 | 91 | $39,700 | $7,683 | 19.4% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 80 | 90 | $36,900 | $5,886 | 16.0% |
| 17000 | Destruction of skin growth | Office | 2021 | 120 | 152 | $61,560 | $5,463 | 8.9% |
About Dr. Daniel Hertel, M.D
Dr. Daniel Hertel, M.D is a Dermatology healthcare provider based in Green Bay, Wisconsin. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/05/2014. The National Provider Identifier (NPI) number assigned to this provider is 1285047373.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Hertel, M.D has received a total of $627.65 in payments from pharmaceutical and medical device companies, with $150.56 received in 2024. These payments were reported across 7 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($562.70).
As a Medicare-enrolled provider, Hertel has provided services to 2,865 Medicare beneficiaries, totaling 4,621 services with total Medicare billing of $185,456. Data is available for 4 years (2020–2023), covering 45 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Location Green Bay, WI
- Active Since 06/05/2014
- Last Updated 08/20/2024
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1285047373
Products in Payments
- Zoryve (Drug) $150.56
- Otezla (Drug) $135.11
- Erivedge (Biological) $118.75
- Tremfya (Drug) $64.95
- Humira (Biological) $41.82
- KYBELLA (Biological) $16.67
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Green Bay
Dr. Semyon Zarkhin, Md, MD
Dermatology — Payments: $13,308
Frances Ballo, Md, MD
Dermatology — Payments: $3,732
Gina Spohn, Md, MD
Dermatology — Payments: $2,504
Paul Stover, Md, MD
Dermatology — Payments: $2,167
Eduardo Moioli
Dermatology — Payments: $242.73
Dr. Rene Earles, Md, MD
Dermatology — Payments: $129.27